Characteristics of Facial Muscle Activity Intensity in Patients With Schizophrenia and Its Relationship to Negative Symptoms

Xia Du, Hong Fan, Yun Hui Wang, Jie Zhang, Xiao Lin Zhu, Yan Li Zhao, Shu Ping TanFrontiers in Psychiatry 2022 · DOI

TL;DR

This study investigated facial muscle activity in individuals with schizophrenia, finding reduced intensity in specific facial muscles compared to healthy controls. These deficits were linked to negative symptoms, suggesting a potential objective marker for assessing symptom severity and guiding treatment.

What Problem Does This Paper Address?

Schizophrenia is characterized by both positive and negative symptoms. While positive symptoms like hallucinations are often prominent, negative symptoms, such as a lack of facial expression and emotional blunting, are equally debilitating and can significantly impair social functioning. Current methods for assessing negative symptoms often rely on subjective clinical judgment or self-report scales, lacking objective, quantitative measures. This paper aims to address this gap by exploring whether objective measurements of facial muscle activity intensity can serve as a quantifiable indicator of negative symptoms in schizophrenia.

Methods

The researchers conducted an observational, cross-sectional study involving 135 patients with schizophrenia and 134 healthy controls. Participants were shown three videos eliciting positive, neutral, and negative emotions. During these video presentations, facial muscle activity was recorded using a high-definition camera. A specialized software program (E-face) processed the data to quantify the intensity of activity across 17 specific facial muscle sites (F01-F17), based on the Facial Action Coding System (FACS). Statistical analyses, including repeated measures ANOVA and logistic regression, were used to compare facial muscle activity between the groups and to explore the relationship between this activity and negative symptoms, as measured by the Brief Negative Symptom Scale (BNSS).

Datasets

The study utilized data collected from 135 patients with schizophrenia and 134 healthy controls. No new benchmark datasets were introduced.

Key Insights and Ideas

  • Objective Measurement of Facial Deficits: The study successfully demonstrated that facial muscle activity intensity can be objectively measured and quantified, offering a potential alternative to subjective assessments of negative symptoms.
  • Specific Muscle Involvement: The findings pinpoint specific facial muscles (e.g., outer eyebrow, upper eyelid, nose, lower jaw, blink) that show reduced activity in individuals with schizophrenia, suggesting a targeted deficit rather than a generalized impairment.
  • Link to Negative Symptoms: The crucial insight is the correlation found between reduced facial muscle activity and the severity of negative symptoms. This suggests that these motor deficits are not merely a byproduct of the illness but are intrinsically linked to the core negative symptomology.
  • Potential for Early Detection and Intervention: By identifying objective markers, this research opens avenues for earlier detection of negative symptoms and more accurate assessment of their severity, which could lead to more timely and effective intervention strategies.

Key Results

  • Patients with schizophrenia exhibited significantly lower facial muscle activity intensity in several key areas (F02, F04, F07, F10, F12, F14, and F17) compared to healthy controls.
  • The intensity of facial muscle activity at F16 (lower jaw 2) was positively correlated with negative symptoms across all emotional stimuli (positive, neutral, and negative).
  • Logistic regression analysis showed that facial muscle activity in several sites (F02, F04, F07, F10, F12, F14, and F17) could accurately predict group membership (schizophrenia vs. healthy control), with an overall accuracy of 73.6%.

Limitations and Future Work

The authors acknowledge several limitations:

  • Cross-sectional Design: The study's cross-sectional nature prevents the dynamic understanding of how facial muscle activity changes over the course of the disease.
  • Medication Effects: The patient group was receiving drug treatment, and the potential influence of antipsychotic medications and their side effects (like Parkinsonian symptoms) on facial muscle activity could not be entirely ruled out.

Future research directions suggested include:

  • Longitudinal Studies: Conducting follow-up studies to track changes in facial muscle activity over time and understand its trajectory in relation to disease progression and treatment.
  • First-Episode Patients: Including patients at their first onset of illness and those not yet undergoing drug treatment to isolate the effects of the illness itself from medication influences.
  • Exploratory Study: Viewing the current study as an exploratory step, with future work needed to further validate these findings and explore the potential of facial muscle activity as a diagnostic or prognostic tool.

Summary updated

Abstract

Our study indicated that patients with schizophrenia show defects in facial muscle activity and that is associated with negative symptoms.
BibTeX
@inproceedings{du2022characteristics,
  author = {Xia Du and Hong Fan and Yun Hui Wang and Jie Zhang and Xiao Lin Zhu and Yan Li Zhao and Shu Ping Tan},
  title = {{Characteristics of Facial Muscle Activity Intensity in Patients With Schizophrenia and Its Relationship to Negative Symptoms}},
  booktitle = {Frontiers in Psychiatry},
  year = {2022},
  doi = {10.3389/fpsyt.2022.829363},
}
Figure